Elekta (OTCMKTS:EKTAY) Sees Strong Trading Volume - Should You Buy?

Shares of Elekta AB (OTCMKTS:EKTAY - Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 20,284 shares traded hands during trading, an increase of 25% from the previous session's volume of 16,196 shares.The stock last traded at $5.34 and had previously closed at $4.98.

Analysts Set New Price Targets

Separately, Danske lowered Elekta to a "hold" rating in a research report on Tuesday, June 3rd.

Elekta Trading Down 0.5%

The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.86 and a current ratio of 1.09. The company has a market cap of $1.96 billion, a P/E ratio of 102.02 and a beta of 1.22. The stock has a 50-day moving average of $5.11 and a two-hundred day moving average of $5.38.

Elekta (OTCMKTS:EKTAY - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.13 by ($0.02). Elekta had a net margin of 1.15% and a return on equity of 11.55%. The company had revenue of $503.22 million for the quarter, compared to the consensus estimate of $507.19 million. On average, equities research analysts predict that Elekta AB will post 0.36 earnings per share for the current year.

About Elekta

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.